Analystreport

Xenon Pharmaceuticals Inc. (NASDAQ: XENE) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $55.00 price target on the stock.

Xenon Pharmaceuticals Inc. - Common Shares  (XENE) 
Last xenon pharmaceuticals inc. - common shares earnings: 11/5 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.xenon-pharma.com